Improved HbA1c: GLP-1 drugs consistently reduce HbA1c an important long-term marker of diabetes control often by 11.5%, depending on the agent and dose
There is no indication of medical efficacy or, in particular, weight loss
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
1.89 0.33 kcal with chow, n = 12, p 200 mg dl 1 ) HFD-fed mice and db/db mice, while it did not alter basal glucose level (around 100 mg dl 1 ) in normal glycemic chow-fed mice
In that one, spending at fast-food chains, coffee shops, and other limited service restaurants fell by 8% when people went on a GLP-1 medication
Signs of a Local Reaction: Symptoms are only at the injection site